fda changes semaglutide 🚨 Ends Shortage The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant Semaglutide: The Drug of Today

Balanced editorial context, not a buying recommendation, current as of April 2026

The decision to use tirzepatide as first-line therapy must consider factors beyond efficacy, including cost, insurance coverage, and patient preferences

Your Provider Makes a Difference Allie Mcallister, NP-C, DCNP Founder & Aesthetic Injector Jessica Beattie, NP-C Aesthetic Injector Mandy Ramer, MSN, NP-C Aesthetic Injector + Hair Loss Expert Sarah Sullivan, MSN, APRN, FNP-C Aesthetic Injector + Wellness Practitioner Care Instructions Here are some helpful instructions to help you plan for before and after your treatment: FAQ Fat dissolving treatments are safe and effective

Verifies the stated weight and concentration is accurate